Zhikun G. Guo

Henan Key Laboratory Of Medical Tissue Regeneration
Xinxiang, 453003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 94 publications

IL-4 peptide hydrogel reprograms MSC heterogeneity toward the CD106+ population for enhanced renal repair.

IL-4 peptide hydrogel reprograms MSC heterogeneity toward the CD106+ population for enhanced renal repair.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: June 10, 2026

Pathological changes in ventricular false chordae tendineae in patients with dilated cardiomyopathy.

Pathological changes in ventricular false chordae tendineae in patients with dilated cardiomyopathy.

Journal: Histology and histopathology

Published: March 30, 2026

Empagliflozin-pirfenidone dual therapy improves cardiac function and structure in a preclinical two-hit HFpEF model.

Empagliflozin-pirfenidone dual therapy improves cardiac function and structure in a preclinical two-hit HFpEF model.

Journal: Frontiers in pharmacology

Published: January 06, 2026

Migration of Cardiac Cells: Hot Topics that have not Attracted Clinical Attention.

Migration of Cardiac Cells: Hot Topics that have not Attracted Clinical Attention.

Journal: International journal of medical sciences

Published: December 23, 2025

Serpine1 Regulates the Enhanced Inhibitory Effect of CHIR99021 Combined with Fibroblast Growth Factor 2 on Myocardial Fibrosis After Myocardial Infarction in Mice.

Serpine1 Regulates the Enhanced Inhibitory Effect of CHIR99021 Combined with Fibroblast Growth Factor 2 on Myocardial Fibrosis After Myocardial Infarction in Mice.

Journal: International journal of molecular sciences

Published: December 23, 2025

Characteristics and Quantitative Analysis of Myocardial Lymphatic Architecture in Patients with Different Types of End-Stage Heart Failure.

Characteristics and Quantitative Analysis of Myocardial Lymphatic Architecture in Patients with Different Types of End-Stage Heart Failure.

Journal: Lymphology

Published: December 17, 2025

Pathological Structural Alterations of Serous Cell Cilia in the Parietal Pericardium of Patients With Heart Failure Induced by Dilated Cardiomyopathy.

Pathological Structural Alterations of Serous Cell Cilia in the Parietal Pericardium of Patients With Heart Failure Induced by Dilated Cardiomyopathy.

Journal: Reviews in cardiovascular medicine

Published: November 10, 2025

CD73+ mesenchymal stem cell (MSC) transplantation improves pressure ulcer healing by promoting angiogenesis through the HIF-1α/VEGF pathway in diabetic mice.

CD73+ mesenchymal stem cell (MSC) transplantation improves pressure ulcer healing by promoting angiogenesis through the HIF-1α/VEGF pathway in diabetic mice.

Journal: Experimental cell research

Published: October 14, 2025

Growth hormone-releasing peptide 6 (GHRP-6) hydrogel for acute kidney injury therapy via metabolic regulation.

Growth hormone-releasing peptide 6 (GHRP-6) hydrogel for acute kidney injury therapy via metabolic regulation.

Journal: Journal of nanobiotechnology

Published: August 22, 2025

Ion channels in macrophages: dynamic regulation in cardiovascular and cerebrovascular diseases and therapeutic potential.

Ion channels in macrophages: dynamic regulation in cardiovascular and cerebrovascular diseases and therapeutic potential.

Journal: Journal of advanced research

Published: July 10, 2025

The Application of Epicardium in Heart Failure Treatment: Opportunities and Challenges.

The Application of Epicardium in Heart Failure Treatment: Opportunities and Challenges.

Journal: International journal of medical sciences

Published: May 28, 2025

Pericardial Administration of Extracellular Vesicles Derived from Bone Marrow Stem Cells Improved Doxorubicin-induced Heart Failure with Mid Range Ejection Fraction (HFmrEF) in Rats.

Pericardial Administration of Extracellular Vesicles Derived from Bone Marrow Stem Cells Improved Doxorubicin-induced Heart Failure with Mid Range Ejection Fraction (HFmrEF) in Rats.

Journal: Cardiovascular drugs and therapy

Published: May 14, 2025

Showing 1-12 of 94

Last Updated: 09/26/2026